Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Recruiting
×
tremelimumab
×
Clear all
Filters
3
NCT06904170
2026-02-03
ALICE
UNICANCER
Phase 2/3
Recruiting
196 enrolled
NCT06109272
2025-08-15
LIVIGNO-2
AbbVie
Phase 2/3
Recruiting
660 enrolled